<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2928273</article-id><article-id pub-id-type="pmid">20811626</article-id><article-id pub-id-type="publisher-id">10-PONE-RA-17637R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0012402</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Oncology</subject><subject>Genetics and Genomics/Genetics of the Immune System</subject><subject>Oncology/Lung Cancer</subject><subject>Oncology/Oncology Agents</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">NSCLC Radiation Toxicity</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hildebrandt</surname><given-names>Michelle A. T.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Komaki</surname><given-names>Ritsuko</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liao</surname><given-names>Zhongxing</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Joe Y.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Yuanqing</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Stewart</surname><given-names>David J.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Minna</surname><given-names>John D.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Roth</surname><given-names>Jack A.</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lippman</surname><given-names>Scott M.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>James D.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Waun Ki</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Spitz</surname><given-names>Margaret R.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Xifeng</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Cordes</surname><given-names>Nils</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Dresden University of Technology, Germany</aff><author-notes><corresp id="cor1">* E-mail: <email>xwu@mdanderson.org</email></corresp><fn fn-type="con"><p><text><SENT sid="1" pm="."><plain>Conceived and designed the experiments: MATH XW. </plain></SENT>
<SENT sid="2" pm="."><plain>Performed the experiments: JG. </plain></SENT>
<SENT sid="3" pm="."><plain>Analyzed the data: MATH YY. </plain></SENT>
<SENT sid="4" pm="."><plain>Contributed reagents/materials/analysis tools: RK ZL JG JYC YY CL DJS JDM JAR SL JDC WKH MRS XW. </plain></SENT>
<SENT sid="5" pm="."><plain>Wrote the paper: MATH XW. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>25</day><month>8</month><year>2010</year></pub-date><volume>5</volume><issue>8</issue><elocation-id>e12402</elocation-id><history><date date-type="received"><day>23</day><month>3</month><year>2010</year></date><date date-type="accepted"><day>2</day><month>8</month><year>2010</year></date></history><permissions><copyright-statement>Hildebrandt et al.</copyright-statement><copyright-year>2010</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis. </plain></SENT>
<SENT sid="7" pm="."><plain>Identifying patients who might be at increased risk for normal tissue toxicity would help in determination of the optimal radiation dose to avoid these events. </plain></SENT>
<SENT sid="8" pm="."><plain>We profiled 59 single nucleotide polymorphisms (SNPs) from 37 inflammation-related genes in 173 NSCLC patients with stage IIIA/IIIB (dry) disease who were treated with definitive radiation or chemoradiation. </plain></SENT>
<SENT sid="9" pm="."><plain>For esophagitis risk, nine SNPs were associated with a 1.5- to 4-fold increase in risk, including three PTGS2 (COX2) variants: rs20417 (HR:1.93, 95% CI:1.10–3.39), rs5275 (HR:1.58, 95% CI:1.09–2.27), and rs689470 (HR:3.38, 95% CI:1.09–10.49). </plain></SENT>
<SENT sid="10" pm="."><plain>Significantly increased risk of pneumonitis was observed for patients with genetic variation in the proinflammatory genes IL1A, IL8, TNF, TNFRSF1B, and MIF. </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, NOS3:rs1799983 displayed a protective effect with a 45% reduction in pneumonitis risk (HR:0.55, 95% CI:0.31–0.96). </plain></SENT>
<SENT sid="12" pm="."><plain>Pneumonitis risk was also modulated by polymorphisms in anti-inflammatory genes, including genetic variation in IL13. </plain></SENT>
<SENT sid="13" pm="."><plain>rs20541 and rs180925 each resulted in increased risk (HR:2.95, 95% CI:1.14–7.63 and HR:3.23, 95% CI:1.03–10.18, respectively). </plain></SENT>
<SENT sid="14" pm="."><plain>The cumulative effect of these SNPs on risk was dose-dependent, as evidenced by a significantly increased risk of either toxicity with an increasing number of risk genotypes (P&lt;0.001). </plain></SENT>
<SENT sid="15" pm="."><plain>These results suggest that genetic variations among inflammation pathway genes may modulate the development of radiation-induced toxicity and, ultimately, help in identifying patients who are at an increased likelihood for such events. </plain></SENT>
</text></SecTag></p></abstract><counts><page-count count="11"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="16" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="17" pm="."><plain>It was predicted that lung cancer would be diagnosed in over 215,000 individuals in the United States alone in 2008 [1]. </plain></SENT>
<SENT sid="18" pm="."><plain>Patients with locally advanced stage IIIA and IIIB (dry) disease who are not candidates for surgery are treated with definitive radiation therapy or combination chemoradiation therapy [2]. </plain></SENT>
<SENT sid="19" pm="."><plain>Unfortunately even with treatment, the overall 5-year survival rate for NSCLC patients is only 10–15% [3]. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>One of the challenges in lung cancer treatment with radiotherapy is the development of severe dose-limiting side effects. </plain></SENT>
<SENT sid="21" pm="."><plain>Esophagitis and pneumonitis are common acute radiation-induced normal tissue toxicities occurring in patients within one year following treatment. </plain></SENT>
<SENT sid="22" pm="."><plain>Presence of these toxicities can also cause a reduction in quality of life and may lead to chronic complications including lung fibrosis [4]. </plain></SENT>
<SENT sid="23" pm="."><plain>Currently, there are few predictors for the development of these toxicities based on clinical and dosimetric parameters [5]–[9]. </plain></SENT>
<SENT sid="24" pm="."><plain>Therefore, the identification of additional reliable markers could help to tailor radiation regimens in order to administer the optimal therapeutic dose while minimizing toxicity. </plain></SENT>
</text></p><p><text><SENT sid="25" pm="."><plain>Inflammation is a physiological response to cellular and tissue damage, including radiation-induced damage. </plain></SENT>
<SENT sid="26" pm="."><plain>Appropriate response to this damage is tightly regulated through a balance between proinflammatory and anti-inflammatory cytokines and signaling molecules [10], [11]. </plain></SENT>
<SENT sid="27" pm="."><plain>Genetic variation in key inflammation-related genes may cause a shift in balance resulting in deregulation of the inflammatory response and corresponding modulation of susceptibility to radiation-induced normal tissue damage [12]. </plain></SENT>
<SENT sid="28" pm="."><plain>Previous studies have investigated genetic variation in transforming growth factor-beta 1 (TGF-β1). </plain></SENT>
<SENT sid="29" pm="."><plain>This important cytokine is up regulated following radiation exposure and common variants located in TGFB1 have been found to be associated with late normal tissue complications [13]–[17]. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>In this study, we utilized a pathway-based approach to analyze genetic variation from 59 SNPs in 37 inflammation-related genes with regard to risk of developing either acute esophagitis or pneumonitis following radiation therapy. </plain></SENT>
<SENT sid="31" pm="."><plain>We explored the main effects of single SNPs and also the cumulative effect of genetic variation within the inflammation pathway on toxicity risk. </plain></SENT>
<SENT sid="32" pm="."><plain>These results indicate that an individual's risk of developing these severe side effects may be modulated by germline variation in inflammation genes and may help to personalize radiation therapy for NSCLC. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="s2"><title><text><SENT sid="33" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="34" pm="."><plain>Patient Characteristics </plain></SENT>
</text></title><p><text><SENT sid="35" pm="."><plain>A total of 173 non-Hispanic Caucasian patients with stage IIIA (n = 70 or 40.5%) or IIIB (dry) (n = 103 or 59.5%) were included in the analysis ( Table 1 ). </plain></SENT>
<SENT sid="36" pm="."><plain>Of these patients, 91 (52.6%) were men and 82 (47.4%) were women with a median age of 63.6 years. </plain></SENT>
<SENT sid="37" pm="."><plain>Most of the patients had a history of smoking with 46.8% (n = 81) being former smokers and 46.2% (n = 80) currently smoking or having quit within a year prior to diagnosis. </plain></SENT>
<SENT sid="38" pm="."><plain>Sixty-three (36.4%) of the tumors were classified as squamous cell carcinoma, 59 (34.1%) as adenocarcinoma, and 40 (23.1%) as non-small cell carcinoma, with the remainder (11 or 6.4%) as other NSCLC. </plain></SENT>
<SENT sid="39" pm="."><plain>Twenty-two patients were given a pre-treatment ECOG performance score ≥2. </plain></SENT>
<SENT sid="40" pm="."><plain>Nearly 80% (n = 138) of the patients received combination chemoradiation therapy, primarily with cisplatin or carboplatin (n = 142). </plain></SENT>
<SENT sid="41" pm="."><plain>A majority were treated with 3D radiotherapy (n = 72 or 41.6%). </plain></SENT>
<SENT sid="42" pm="."><plain>There were 78 occurrences of grade ≥2 esophagitis and 43 of grade ≥2 pneumonitis in our population. </plain></SENT>
<SENT sid="43" pm="."><plain>Twenty-three of these patients had both esophagitis and pneumonitis, while 75 patients had neither. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0012402-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="44" pm="."><plain>Patient characteristics. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0012402-t001-1" xlink:href="pone.0012402.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1"><text><SENT sid="45" pm="."><plain>Esophagitis </plain></SENT>
</text></td><td colspan="3" align="left" rowspan="1"><text><SENT sid="46" pm="."><plain>Pneumonitis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="47" pm="."><plain>Overall </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="49" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>P value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>P value </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>Gender </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>Male </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>91 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>50(52.63) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>41(52.56) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>73(56.15) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>18(41.86) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>Female </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>82 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>45(47.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>37(47.44) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>0.993 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>57(43.85) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>25(58.14) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>0.104 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>Age, mean(SD) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>63.60(9.98) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>64.85(10.14) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>62.08(9.64) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>0.069 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>64.18(10.02) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>61.86(9.78) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>0.188 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Smoking status </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>Never </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>6(6.32) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>6(7.69) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>8(6.15) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>4(9.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>Former </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>81 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>47(49.47) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>34(43.59) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>53(40.77) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>28(65.12) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>Current &amp; Recent Quitter </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>80 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>42(44.21) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>38(48.72) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>0.733 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>69(53.08) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>11(25.58) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>0.007 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>Packyr, mean(SD) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>51.62(28.67) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>53.67(28.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>49.08(29.04) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>0.315 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>53.71(29.41) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>45.07(25.48) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>0.102 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>Histology </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>Adenocarcinoma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>26(27.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>33(42.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>42(32.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>17(39.53) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>Squamous Cell Carcinoma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>41(43.16) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>22(28.21) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>48(36.92) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>15(34.88) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>Non-small Cell Carcinoma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>40 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>21(22.11) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>19(24.36) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>33(25.38) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>7(16.28) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>Other NSCLC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>7(7.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>4(5.13) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>0.118 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>7(5.38) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>4(9.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>0.481 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>Clinical stage </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>Stage IIIA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>41(43.16) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>29(37.18) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>46(35.38) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>24(55.81) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Stage IIB(dry) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>103 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>54(56.84) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>49(62.82) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>0.425 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>84(64.62) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>19(44.19) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>0.018 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>Performance status </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>23(24.21) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>29(37.18) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>38(29.23) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>14(32.56) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>59(62.11) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>40(51.28) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>75(57.69) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>24(55.81) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>2–4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>13(13.68) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>9(11.54) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>0.180 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>17(13.08) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>5(11.63) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>0.908 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>Treatment </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>Radiation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>31(32.63) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>4(5.13) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>29(22.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>6(13.95) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Chemoradiation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>138 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>64(67.37) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>74(94.87) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>101(77.69) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>37(86.05) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>0.237 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>Radiation type </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>2D </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>36(37.89) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>19(24.36) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>47(36.15) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>8(18.60) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>3D </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>29(30.53) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>43(55.13) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>46(35.38) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>26(60.47) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>IMRT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>46 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>30(31.58) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>16(20.51) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>0.005 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>37(28.46) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>9(20.93) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>0.013 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>Total </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>173 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>130 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>Radiation dose, mean(SD) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>62.34(10.40) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>60.75(12.64) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>64.27(6.29) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>0.026 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>61.68(11.63) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>64.32(4.66) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>0.149 </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag><p><text><SENT sid="255" pm="."><plain>There were no significant differences between patients who developed severe esophagitis and those who did not with regard to age, gender, smoking status, histology, clinical stage and performance status. </plain></SENT>
<SENT sid="256" pm="."><plain>However, patients who developed esophagitis were more likely to receive chemoradiation instead of radiation alone (P&lt;0.001), and more likely to receive a higher mean radiation dose (P = 0.026) compared to those who did not develop esophagitis. </plain></SENT>
<SENT sid="257" pm="."><plain>Interestingly, severe pneumonitis was more frequent in patients who were former smokers compared to current smokers or recent quitters (P = 0.007). </plain></SENT>
<SENT sid="258" pm="."><plain>Patients with stage IIIA patients were also more likely to develop pneumonitis (P = 0.018). </plain></SENT>
<SENT sid="259" pm="."><plain>For both esophagitis and pneumonitis, there was a significant difference in the occurrence of toxicity by the type of radiation therapy administered (P = 0.005 and 0.013, respectively). </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="260" pm="."><plain>Inflammation-related SNPs and Risk of Esophagitis </plain></SENT>
</text></title><p><text><SENT sid="261" pm="."><plain>Among the 59 SNPs studied, a total of nine inflammation-related SNPs were found to be significantly associated with risk of esophagitis following radiation treatment ( Table 2 ). </plain></SENT>
<SENT sid="262" pm="."><plain>All of these variants remained significant at an FDR level of 10%. </plain></SENT>
<SENT sid="263" pm="."><plain>In addition, because esophagitis typically presents 4–6 weeks following initiation of radiation therapy, we also analyzed the effect of these variants using logistic regression. </plain></SENT>
<SENT sid="264" pm="."><plain>The results are similar to those from the Cox regression analysis (data not shown). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0012402-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="265" pm="."><plain>Inflammation-related SNPs and risk of esophagitis. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0012402-t002-2" xlink:href="pone.0012402.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>*HR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>P value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>Q value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>*HR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>P value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>Q value </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="13" align="left" rowspan="1"><text><SENT sid="278" pm="."><plain>Proinflammatory cytokines, receptors, and related molecules </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>IL6:rs1800795 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>PTGS2:rs20417 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>32(34.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>30(39.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>82(87.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>54(71.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>CG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>53(56.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>27(35.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>0.67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>0.38 to 1.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>0.162 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>GC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>12(12.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>20(26.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>1.90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>1.07 to 3.39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>0.029 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>9(9.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>19(25.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>1.70 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>0.87 to 3.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>0.123 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>0(0.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>2(2.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>CC+CG vs. GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>85 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>57 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>2.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>1.18 to 3.94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>0.013 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>0.052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>GC+CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>1.93 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>1.10 to 3.39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>0.029 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>0.052 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>IL16:rs11556218 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>PTGS2:rs5275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>92 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>58(60.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>41(54.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>51(55.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>32(42.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>TG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>32(33.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>22(29.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>0.86 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>0.49 to 1.53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>0.615 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>TC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>39(42.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>33(44.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>1.43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>0.85 to 2.39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>0.178 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>6(6.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>12(16.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>2.14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>1.05 to 4.36 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>0.035 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>2(2.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>10(13.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>2.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>1.25 to 5.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>0.011 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>TT+TG vs. GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>2.28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>1.16 to 4.47 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>0.017 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>0.052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>P for trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>1.58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>1.09 to 2.27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>0.014 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>0.052 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>TNF:rs1799724 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>92 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>PTGS2:rs689470 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>74(80.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>50(70.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>92(72.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>70(94.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>12(13.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>20(28.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>2.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>1.17 to 3.86 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>0.013 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>4(4.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>3(4.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>2.67 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>0.73 to 9.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>0.136 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>0.072 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>6(6.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>1(1.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>0.91 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>0.12 to 6.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>0.928 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>0(0.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>1(1.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>CT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>1.97 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>1.10 to 3.50 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>0.022 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>0.052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>CT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>3.38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>1.09 to 10.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>0.035 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="13" align="left" rowspan="1"><text><SENT sid="427" pm="."><plain>Anti-inflammatory cytokines, receptors, and related molecules </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>IL4R:rs1801275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>IL10RA:rs3135932 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>60(63.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>40(53.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>68(71.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>43(56.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>AG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>34(36.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>28(37.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>0.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>0.58 to 1.68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>0.973 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>AG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>24(25.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>28(36.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>1.38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>0.83 to 2.28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>0.217 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>0(0.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>7(9.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>3(3.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>5(6.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>2.60 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>0.99 to 9.83 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>0.053 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>AA+AG vs. GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>4.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>1.60 to 10.59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>0.003 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>0.052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>P for trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>1.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>1.01 to 2.20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>0.046 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>0.083 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>IL10:rs1800872 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>65(69.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>43(57.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>CA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>27(28.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>26(34.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>1.59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>0.93 to 2.72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>0.093 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>2(2.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>6(8.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>2.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>1.15 to 7.22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>0.024 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>P for trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>1.65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>1.11 to 2.45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>0.013 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>0.052 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="499" pm="."><plain>*adjusted for age, gender, pack years, clinical stage, performance status, treatment regimen, radiation type, and radiation dosage. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><sec id="s2b1"><title><text><SENT sid="500" pm="."><plain>Proinflammatory Genes </plain></SENT>
</text></title><p><text><SENT sid="501" pm="."><plain>Of these nine SNPs, six were among genes involved in the proinflammatory response: IL6, IL16, TNF, and PTGS2 (COX2). </plain></SENT>
<SENT sid="502" pm="."><plain>Interleukin 6 (IL6):rs1800795 resulted in an 2.16-fold increased risk (95% CI:1.18–3.94) under the recessive model. </plain></SENT>
<SENT sid="503" pm="."><plain>A similar effect was observed for IL16:rs11556218 (HR:2.28, 95% CI:1.16–4.47). </plain></SENT>
<SENT sid="504" pm="."><plain>Patients with at least one tumor necrosis factor-α (TNF) variant rs1799724 had a nearly 2-fold increased risk (HR:1.97, 95% CI:1.10–3.50). </plain></SENT>
<SENT sid="505" pm="."><plain>Three SNPs in PTGS2 modulated esophagitis risk in our patient population: rs20417, rs5275, and rs689470. </plain></SENT>
<SENT sid="506" pm="."><plain>PTGS2:rs5275 was associated with an increased risk (P for trend  = 0.014). </plain></SENT>
<SENT sid="507" pm="."><plain>For rs20417 and rs689470, carriers of at least one variant allele were at an increased risk (HR:1.93, 95% CI:1.10–3.39 and HR:3.38, 95% CI:1.09–10.49, respectively). </plain></SENT>
</text></p></sec><sec id="s2b2"><title><text><SENT sid="508" pm="."><plain>Anti-inflammatory Genes </plain></SENT>
</text></title><p><text><SENT sid="509" pm="."><plain>SNPs in the IL4 receptor, IL10, and the alpha subunit of the IL10 receptor were found to be significantly associated with increased esophagitis risk. </plain></SENT>
<SENT sid="510" pm="."><plain>The IL10:rs1800872 and IL10RA:rs3135932 variants were both associated with significantly increased risks under the additive model with HRs of 1.65 (95% CI: 1.11–2.45) and 1.49 (95% CI: 1.01–2.20), respectively. </plain></SENT>
<SENT sid="511" pm="."><plain>IL4R:rs1801275 resulted in over a 4-fold increased risk (HR:4.12, 95% CI:1.60–10.59). </plain></SENT>
</text></p></sec><sec id="s2b3"><title><text><SENT sid="512" pm="."><plain>Joint Analysis of Esophagitis Risk Alleles </plain></SENT>
</text></title><p><text><SENT sid="513" pm="."><plain>To understand the cumulative effect of unfavorable genotypes on risk of esophagitis, we performed a combined analysis. </plain></SENT>
<SENT sid="514" pm="."><plain>We included all significant SNPs identified from our individual SNP analysis and an additional seven SNPs reaching borderline significance at p&lt;0.10 ( Table 3 ). </plain></SENT>
<SENT sid="515" pm="."><plain>Patients with four unfavorable genotypes had a 3.71-fold increased risk (95% CI:1.53–8.99) compared to those with 0∼3 unfavorable genotypes. </plain></SENT>
<SENT sid="516" pm="."><plain>This risk increased to 8.85 (95% CI:4.19–18.68) for patients with five or more unfavorable genotypes. </plain></SENT>
<SENT sid="517" pm="."><plain>Furthermore, patients with an increasing number of unfavorable genotypes developed esophagitis significantly quicker following initiation of radiation therapy ( Figure 1A ). </plain></SENT>
<SENT sid="518" pm="."><plain>Carriers of five or more unfavorable genotypes had a median time to event of only 1.1 months compared to over 12 months for those with three or less unfavorable genotypes (P&lt;0.0001). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0012402-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="519" pm="."><plain>Event-free survival by number of unfavorable genotypes in inflammation-related genes. </plain></SENT>
</text></title><p><text><SENT sid="520" pm="."><plain>Kaplan-Meier curves of freedom from (A) grade &gt;2 esophagitis or (B) grade &gt;2 pneumonitis following radiation therapy. </plain></SENT>
<SENT sid="521" pm="."><plain>Numbers in parentheses are the number of patients with toxicity over the total number of patients; time is median event-free duration in months. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0012402.g001"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0012402-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="522" pm="."><plain>Cumulative effect of unfavorable genotypes and radiation-induced toxicity risk. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0012402-t003-3" xlink:href="pone.0012402.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>Number of Unfavorable Genotypes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>Grade &lt;2 n </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>Grade ≥2 n </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>*HR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>P value </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>#Esophagitis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>0∼3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>3.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>1.53 to 8.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>0.004 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>≥5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>8.85 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>4.19 to 18.68 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>P trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td colspan="6" align="left" rowspan="1"><text><SENT sid="548" pm="."><plain>&amp; Phenumonitis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>0∼2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>17 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>13.30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>1.72 to 102.94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>0.013 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>≥4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>69.42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>8.62 to 558.91 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>P trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p><text><SENT sid="567" pm="."><plain>*adjusted for age, gender, pack years, clinical stage, performance status, treatment regimen, </plain></SENT>
</text></p></fn><fn id="nt103"><label/><p><text><SENT sid="568" pm="."><plain>radiation type, and radiation dosage. </plain></SENT>
</text></p></fn><fn id="nt104"><label/><p><text><SENT sid="569" pm="."><plain>#unfavorable genotypes: IL6:rs1800795, IL16:rs11556218, TNF:rs1799724, PTGS2:rs20417. </plain></SENT>
</text></p></fn><fn id="nt105"><label/><p><text><SENT sid="570" pm="."><plain>PTGS2:rs5275, PTGS2:rs689470, IL4R:rs1801275, IL10:rs1800872, IL10RA:rs3135932. </plain></SENT>
</text></p></fn><fn id="nt106"><label/><p><text><SENT sid="571" pm="."><plain>IL1B:rs16944, IL2RB:rs228942, IL8:rs4073, IL10RB:rs2834167, IL13:rs1800925, NOS2:rs2297518. </plain></SENT>
</text></p></fn><fn id="nt107"><label>&amp;</label><p><text><SENT sid="572" pm="."><plain>unfavorable genotypes: IL1A:rs1800587, IL8:rs4073, TNF:rs1799724, TNFRSF1B:rs1061622. </plain></SENT>
</text></p></fn><fn id="nt108"><label/><p><text><SENT sid="573" pm="."><plain>MIF:rs7555622, IL4:rs2243250, IL4R:rs2070874, IL13:rs10800925, IL13:rs20541, NOS3:rs1799983, NFKBIA:rs1799983. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec></sec><sec id="s2c"><title><text><SENT sid="574" pm="."><plain>Inflammation-related SNPs and Risk of Pneumonitis </plain></SENT>
</text></title><p><text><SENT sid="575" pm="."><plain>A different set of inflammation-related SNPs was found to be significantly associated with risk of developing pneumonitis following radiation therapy and remained so at an FDR of 10% ( Table 4 ). </plain></SENT>
<SENT sid="576" pm="."><plain>Only one of the 12 SNPs identified were also associated with esophagitis risk – TNF:rs1799724. </plain></SENT>
<SENT sid="577" pm="."><plain>Patients homozygous for this variant exhibited a 5.96-fold increased risk (95% CI:1.33–18.57) of pneumonitis. </plain></SENT>
<SENT sid="578" pm="."><plain>This risk is similar for esophagitis risk in patients carrying at least one variant allele ( Table 2 ). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0012402-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="579" pm="."><plain>Inflammation-related SNPs and risk of pneumonitis. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0012402-t004-4" xlink:href="pone.0012402.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>*HR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>P value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>Q value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>Grade &lt;2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>Grade ≥2 n(%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>*HR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>95% CI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>P value </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>Q value </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="13" align="left" rowspan="1"><text><SENT sid="592" pm="."><plain>Proinflammatory cytokines, receptors, and related molecules </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>IL1A:rs1800587 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>128 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>TNFRSF1B:rs1061622 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>126 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>65(50.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>11(25.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>72(57.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>17(40.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>51(39.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>30(69.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>3.66 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>1.66 to 8.07 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>0.001 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>TG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>50(39.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>22(52.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>1.84 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>0.90 to 3.79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>0.096 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>12(9.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>2(4.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>0.89 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>0.19 to 4.23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>0.885 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>4(3.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>3(7.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>5.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>1.50 to 23.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>0.011 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>CT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>2.90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>1.34 to 6.25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>0.007 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>0.021 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>P for trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>2.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>1.18 to 3.79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>0.012 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>0.023 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>IL1A:rs17561 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>128 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>MIF:rs755622 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>126 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>65(50.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>12(27.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>89(70.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>26(60.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>GT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>52(40.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>29(67.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>3.11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>1.44 to 6.72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>0.004 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>CG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>32(25.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>12(27.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>1.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>0.69 to 3.24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>0.312 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>11(8.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>2(4.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>0.85 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>0.18 to 4.01 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>0.836 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>5(4.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>5(11.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>4.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>1.14 to 17.66 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>0.031 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>GT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>31 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>2.51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>1.19 to 5.27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>0.015 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>0.024 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>CC+CG vs. GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="689" pm="."><plain>121 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>3.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>1.04 to 15.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>0.044 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>0.038 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>IL8:rs4073 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>128 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>NOS3:rs1799983 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="699" pm="."><plain>129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="700" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="701" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="702" pm="."><plain>37(28.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="703" pm="."><plain>7(17.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="704" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="705" pm="."><plain>GG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="706" pm="."><plain>51(39.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="707" pm="."><plain>22(52.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="708" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="709" pm="."><plain>TA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="710" pm="."><plain>66(51.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="711" pm="."><plain>19(46.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="712" pm="."><plain>1.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="713" pm="."><plain>0.51 to 3.56 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="714" pm="."><plain>0.548 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="715" pm="."><plain>GT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="716" pm="."><plain>61(47.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="717" pm="."><plain>17(40.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="718" pm="."><plain>0.53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="719" pm="."><plain>0.27 to 1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="720" pm="."><plain>0.067 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="721" pm="."><plain>AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>25(19.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>15(36.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>3.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>1.42 to 10.62 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>0.008 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>17(13.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>3(7.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>0.34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="731" pm="."><plain>0.08 to 1.51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>0.157 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>TT+TA vs. AA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>103 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>3.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>1.54 to 6.48 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>0.002 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>0.010 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>P for trend </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>0.55 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>0.31 to 0.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>0.037 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>0.038 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>TNF:rs1799724 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="746" pm="."><plain>121 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>94(77.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>30(71.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>23(19.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>9(21.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>1.45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>0.64 to 3.26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>0.370 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>4(3.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>3(7.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="761" pm="."><plain>5.32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>1.40 to 20.22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>0.014 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>CC+CT vs. TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>117 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>4.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>1.33 to 18.57 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="769" pm="."><plain>0.017 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>0.024 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="13" align="left" rowspan="1"><text><SENT sid="771" pm="."><plain>Anti-inflammatory cytokines, receptors, and related molecules </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>IL4:rs2243250 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>128 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>IL13:rs20541 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>103(80.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>27(64.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>88(68.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="784" pm="."><plain>28(65.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>22(17.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>13(31.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>2.50 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>1.22 to 5.11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>0.012 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>35(27.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>9(20.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>0.98 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>0.43 to 2.25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>0.968 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="799" pm="."><plain>3(2.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>2(4.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>3.10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>0.34 to 28.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>0.313 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="805" pm="."><plain>6(4.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="806" pm="."><plain>6(14.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="807" pm="."><plain>2.94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="808" pm="."><plain>1.12 to 7.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="809" pm="."><plain>0.028 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="810" pm="."><plain>CT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="811" pm="."><plain>25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="812" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="813" pm="."><plain>2.54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="814" pm="."><plain>1.27 to 5.08 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="815" pm="."><plain>0.008 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="816" pm="."><plain>0.021 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="817" pm="."><plain>CC+CT vs. TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="818" pm="."><plain>123 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="819" pm="."><plain>37 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="820" pm="."><plain>2.95 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="821" pm="."><plain>1.14 to 7.63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="822" pm="."><plain>0.025 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="823" pm="."><plain>0.031 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="824" pm="."><plain>IL4:rs2070874 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="825" pm="."><plain>128 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="826" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="827" pm="."><plain>IL13:rs180925 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="828" pm="."><plain>129 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="829" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="830" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="831" pm="."><plain>104(81.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="832" pm="."><plain>27(62.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="833" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="834" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="835" pm="."><plain>83(64.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="836" pm="."><plain>26(60.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="837" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="838" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="839" pm="."><plain>21(16.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="840" pm="."><plain>15(34.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="841" pm="."><plain>3.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="842" pm="."><plain>1.49 to 6.44 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="843" pm="."><plain>0.003 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="844" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="845" pm="."><plain>42(32.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="846" pm="."><plain>13(30.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="847" pm="."><plain>0.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="848" pm="."><plain>0.33 to 1.52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="849" pm="."><plain>0.380 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="850" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="851" pm="."><plain>3(2.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="852" pm="."><plain>1(2.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="853" pm="."><plain>2.59 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="854" pm="."><plain>0.27 to 24.47 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="855" pm="."><plain>0.405 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="856" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="857" pm="."><plain>4(3.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="858" pm="."><plain>4(9.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="859" pm="."><plain>2.97 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="860" pm="."><plain>0.93 to 9.45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="861" pm="."><plain>0.066 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="862" pm="."><plain>CT+TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="863" pm="."><plain>24 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="864" pm="."><plain>16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="865" pm="."><plain>3.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="866" pm="."><plain>1.50 to 6.22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="867" pm="."><plain>0.002 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="868" pm="."><plain>0.010 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="869" pm="."><plain>CC+CT vs. TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="870" pm="."><plain>125 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="871" pm="."><plain>39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="872" pm="."><plain>3.23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="873" pm="."><plain>1.03 to 10.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="874" pm="."><plain>0.045 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="875" pm="."><plain>0.038 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="876" pm="."><plain>NFKBIA:rs8904 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="877" pm="."><plain>127 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="878" pm="."><plain>43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="879" pm="."><plain>CC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="880" pm="."><plain>54(42.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="881" pm="."><plain>12(27.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="882" pm="."><plain>1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="883" pm="."><plain>CT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="884" pm="."><plain>53(41.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="885" pm="."><plain>16(37.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="886" pm="."><plain>0.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="887" pm="."><plain>0.42 to 2.30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="888" pm="."><plain>0.974 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="889" pm="."><plain>TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="890" pm="."><plain>20(15.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="891" pm="."><plain>15(34.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="892" pm="."><plain>2.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="893" pm="."><plain>0.84 to 4.79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="894" pm="."><plain>0.119 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="895" pm="."><plain>CC+CT vs. TT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="896" pm="."><plain>107 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="897" pm="."><plain>28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="898" pm="."><plain>2.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="899" pm="."><plain>1.01 to 4.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="900" pm="."><plain>0.047 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt109"><label/><p><text><SENT sid="901" pm="."><plain>*adjusted for age, gender, pack years, clinical stage, performance status, treatment regimen, radiation type, and radiation dosage. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><sec id="s2c1"><title><text><SENT sid="902" pm="."><plain>Proinflammatory Genes </plain></SENT>
</text></title><p><text><SENT sid="903" pm="."><plain>Other significant genetic variants associated with pneumonitis included six SNPs in proinflammatory genes, including IL1A, IL8, TNFRSF1B, MIF, and NOS3. </plain></SENT>
<SENT sid="904" pm="."><plain>Two SNPs in IL1A – rs1800587 and rs17561– are in strong linkage disequilibrium and each resulted in a more than doubling of risk with HRs of 2.90 (95% CI:1.34–6.25) and 2.51 (95% CI:1.19–5.27), respectively. </plain></SENT>
<SENT sid="905" pm="."><plain>The risk associated with IL8:rs4073 was similar at 3.16-fold (95% CI:1.54–6.48). </plain></SENT>
<SENT sid="906" pm="."><plain>Under the additive model, TNFRSF1B:rs1061622 resulted in a 2.12-fold increased risk (95% CI:1.18–3.79). </plain></SENT>
<SENT sid="907" pm="."><plain>A SNP in the lymphokine gene MIF resulted in an even higher HR of 3.96 (95% CI:1.04–15.12). </plain></SENT>
<SENT sid="908" pm="."><plain>In contrast, genetic variation in NOS3 was associated with a 50% decrease in pneumonitis risk (HR:0.55, 95% CI:0.31–0.96). </plain></SENT>
<SENT sid="909" pm="."><plain>This was the only SNP in our analysis to be significantly associated with a reduction in risk. </plain></SENT>
</text></p></sec><sec id="s2c2"><title><text><SENT sid="910" pm="."><plain>Anti-inflammatory Genes </plain></SENT>
</text></title><p><text><SENT sid="911" pm="."><plain>IL4 and IL13 share a common receptor and have many of the same anti-inflammatory functions. </plain></SENT>
<SENT sid="912" pm="."><plain>In our population, we found that genetic variations in both of these interleukins were associated with increased risks of developing pneumonitis. </plain></SENT>
<SENT sid="913" pm="."><plain>The two IL4 SNPs each resulted in increased risk with HRs of 2.54 (95% CI:1.27–5.08) and 3.05 (95% CI:1.50–6.22), respectively. IL13 polymorphisms had a similar effect on pneumonitis risk. </plain></SENT>
<SENT sid="914" pm="."><plain>Patients with two variant alleles or either rs20541 or rs180925 were approximately 3-times more likely to develop pneumonitis compared to those with wild-type or heterozygous genotypes (HR:2.95, 95% CI:1.14–7.63 and HR:3.23, 95% CI:1.03–10.18). </plain></SENT>
<SENT sid="915" pm="."><plain>The signaling molecule IkappaB-alpha (NFKBIA) inhibits the inflammatory response by blocking NFkappaB-mediated transcription of proinflammatory genes. </plain></SENT>
<SENT sid="916" pm="."><plain>NFKBIA:rs8904 resulted in a 2.02-fold increased pneumonitis risk (95% CI:1.01–4.03). </plain></SENT>
</text></p></sec><sec id="s2c3"><title><text><SENT sid="917" pm="."><plain>Joint Analysis of Pneumonitis Risk Alleles </plain></SENT>
</text></title><p><text><SENT sid="918" pm="."><plain>In combined analysis, the significant SNPs together with an additional borderline significant variant – IL4R: rs1801275 (P = 0.053) – showed an increase in pneumonitis risk as the number of unfavorable genotypes increased ( Table 3 ). </plain></SENT>
<SENT sid="919" pm="."><plain>The increased risk for carrying three unfavorable genotypes was 13.30-fold compared to patients with 0 to 2 risk genotypes (P = 0.013). </plain></SENT>
<SENT sid="920" pm="."><plain>This risk was dramatically increased for the group of patients with four or more unfavorable genotypes (P&lt;0.0001). </plain></SENT>
<SENT sid="921" pm="."><plain>These high risk individuals also had a shorter duration between start of treatment and development of pneumonitis of only 5.33 months compared to over 12 months for those with 0 to 2 unfavorable genotypes ( Figure 1B ). </plain></SENT>
</text></p></sec></sec><sec id="s2d"><title><text><SENT sid="922" pm="."><plain>Inflammation-related SNPs and Overall Survival </plain></SENT>
</text></title><p><text><SENT sid="923" pm="."><plain>The development of toxicity and survival are often related since patients who develop toxicity are those who are responding to treatment. </plain></SENT>
<SENT sid="924" pm="."><plain>Therefore, we determined if any of the variants identified as toxicity risk factors were also associated with survival over three years. </plain></SENT>
<SENT sid="925" pm="."><plain>We found that patients with at least one variant allele of IL10:rs1800872 had a 1.74-fold increased risk of esophagitis, but a 40% decreased risk of dying when compared to patients with wild-type genotypes (HR:0.62, 95% CI:0.40–0.97).  Figure 2A  illustrates the time to esophagitis for patients with IL10:rs1800872 genotypes. </plain></SENT>
<SENT sid="926" pm="."><plain>Although not significant, patients with wild-type genotypes had median time to event of greater than 12 months contrasted with only 1.8 months for those with at least one variant of rs1800872. </plain></SENT>
<SENT sid="927" pm="."><plain>For survival ( Figure 2B ), there was a non-significant survival advantage of nearly four months for carriers with a median survival time of 16.1 months compared to only 12.4 months for patients with wild-type genotypes. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0012402-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="928" pm="."><plain>Relationship between esophagitis and overall survival. </plain></SENT>
</text></title><p><text><SENT sid="929" pm="."><plain>(A) Kaplan-Meier curves of freedom from grade &gt;2 esophagitis following radiation therapy by IL10:rs1800872 genotypes. </plain></SENT>
<SENT sid="930" pm="."><plain>Numbers in parentheses are the number of patients with toxicity over the total number of patients; time is median event-free duration in months. </plain></SENT>
<SENT sid="931" pm="."><plain>(B) Kaplan-Meier curves of overall survival following radiation therapy by IL10:rs1800872 genotypes. </plain></SENT>
<SENT sid="932" pm="."><plain>Numbers in parentheses are the number of patients alive over the total number of patients; time is median survival time in months. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0012402.g002"/></fig></SecTag></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s3"><title><text><SENT sid="933" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="934" pm="."><plain>In this study, we systematically analyzed 59 common genetic variations in inflammation-related genes for association with risk of developing acute esophagitis or pneumonitis following radiation treatment in NSCLC patients. </plain></SENT>
<SENT sid="935" pm="."><plain>Multiple individual SNPs in important pro- and anti-inflammatory genes were identified as modulating risk for both normal tissue toxicities. </plain></SENT>
<SENT sid="936" pm="."><plain>Furthermore, the cumulative effect of these SNPs was dose-dependent with individuals carrying multiple unfavorable alleles having a corresponding increase in risk. </plain></SENT>
</text></p><p><text><SENT sid="937" pm="."><plain>Nine genetic variants were identified as significantly associated with esophagitis risk, and of those, six were in proinflammatory genes ( Table 2 ). </plain></SENT>
<SENT sid="938" pm="."><plain>We found that rs1800795 in IL6 resulted in a 2.16-fold increase in esophagitis. </plain></SENT>
<SENT sid="939" pm="."><plain>This polymorphism is located within the 5′-untranslated region of IL6 and has been functionally studied with conflicting results of the effect on gene expression and response to stimulation [18], [19]. </plain></SENT>
<SENT sid="940" pm="."><plain>However, a recent meta-analysis of over 5,500 patients was not able to demonstrate a relationship between this variant and IL6 serum levels [20]. </plain></SENT>
<SENT sid="941" pm="."><plain>Gao et al. demonstrated that IL16:rs11556218 was significantly associated with colorectal and gastric cancer, but did not observe a correlation between IL16 serum levels measured in these patients and rs11556218 [21]. </plain></SENT>
<SENT sid="942" pm="."><plain>PTGS2:rs20417 was also associated with increased risk of esophagitis. </plain></SENT>
<SENT sid="943" pm="."><plain>This promoter variant disrupts a Sp1/Sp3 transcription factor binding site and causes a decrease in transcriptional activity in lung fibroblast cells [22], [23]. </plain></SENT>
<SENT sid="944" pm="."><plain>Decreased expression of COX2 would suggest a decrease in inflammation signaling. </plain></SENT>
<SENT sid="945" pm="."><plain>However, this same variant, while altering the Sp1/Sp3 site, also introduces a binding site for another transcription factor, Egr-1, although the consequences are unknown [22]. </plain></SENT>
<SENT sid="946" pm="."><plain>The other two significant variants (rs5275 and rs689470) are located in the 3′-UTR and regulate PSTGS2 mRNA levels. </plain></SENT>
<SENT sid="947" pm="."><plain>Our results suggest that these SNPs are linked with an increase in pro-inflammatory activity leading to esophagitis. </plain></SENT>
<SENT sid="948" pm="."><plain>Further functional analysis is warranted to understand the underlying mechanisms [24]. </plain></SENT>
</text></p><p><text><SENT sid="949" pm="."><plain>For anti-inflammatory molecules and esophagitis risk, Khurana Hershey et al. demonstrated that IL4R:rs1801275 resulted in enhanced IL4 signaling and the induction of high levels of the IgE receptor CD23 [25]. </plain></SENT>
<SENT sid="950" pm="."><plain>IL10:rs1800872 and IL10RA:rs3135932 have been shown to decrease IL10 signaling by decreasing serum levels and altering IL10-IL10RA interactions, respectively [26], [27]. </plain></SENT>
<SENT sid="951" pm="."><plain>The reported functions of these three SNPs would be in agreement with our findings of an increased risk of esophagitis by decreasing the anti-inflammatory response. </plain></SENT>
</text></p><p><text><SENT sid="952" pm="."><plain>Twelve common polymorphisms were found to be significantly associated with risk of pneumonitis. </plain></SENT>
<SENT sid="953" pm="."><plain>The two IL1A variants are in linkage disequilibrium and were found to increase risk by nearly 3-fold. </plain></SENT>
<SENT sid="954" pm="."><plain>IL1A:rs1800587 has been shown to contribute to an increase in IL1-α promoter activity, mRNA levels and protein levels [28]. </plain></SENT>
<SENT sid="955" pm="."><plain>IL1A:rs17561 is a non-synonymous SNP and increases processing of the IL1-α precursor resulting in an increase in the levels of active IL1-α [29]. </plain></SENT>
<SENT sid="956" pm="."><plain>The variant of IL8:rs4073, which was found to increase pneumonitis risk 3-fold, has been associated with increased secretion of the proinflammatory cytokine IL8 [30]. </plain></SENT>
<SENT sid="957" pm="."><plain>IL4 and IL13 work together to regulate the inflammatory response. </plain></SENT>
<SENT sid="958" pm="."><plain>Four genetic variants in these two genes were associated with ∼3-fold increased risk of pneumonitis. </plain></SENT>
<SENT sid="959" pm="."><plain>Studies have demonstrated increased IgE production for IL4:rs2070874 and rs2243250 [31] and increased IL13 activity for IL13:rs20541 and rs180925 [32], [33]. </plain></SENT>
</text></p><p><text><SENT sid="960" pm="."><plain>Genetic variation in TNF and the receptor TNFRSF1B were also associated with increased risk of pneumonitis. </plain></SENT>
<SENT sid="961" pm="."><plain>TNF-α signaling is an important modulator of the inflammatory response. </plain></SENT>
<SENT sid="962" pm="."><plain>The TNF:rs1799724 variant is located within the promoter region of the gene and thought to influence gene expression by creating an OCT-1 transcription factor binding site [34]. </plain></SENT>
<SENT sid="963" pm="."><plain>The effect of this differential binding on TNF-α signaling is not clear. </plain></SENT>
<SENT sid="964" pm="."><plain>Some studies have shown an increase in TNF-α production [35], [36], [37], while others have shown the opposite effect [38], [39], [40]. </plain></SENT>
<SENT sid="965" pm="."><plain>For TNFRSF1B, the non-synonymous variant Met196Arg (rs1061622) does not alter TNF-α binding affinity, but results in intensified TNF-α signaling [41] and decreased NF-kB signaling [42]. </plain></SENT>
</text></p><p><text><SENT sid="966" pm="."><plain>Only one genetic variant was found to confer a protective effect following radiotherapy. </plain></SENT>
<SENT sid="967" pm="."><plain>This variant, rs1799983, in NOS3 was associated with a 70% reduction in risk of pneumonitis. </plain></SENT>
<SENT sid="968" pm="."><plain>Functional studies have demonstrated that this variant results in production of a variant allozyme with reduced enzyme activity [43] resulting in a reduction in nitric oxide production [44]. </plain></SENT>
<SENT sid="969" pm="."><plain>These observations support our findings of decreased pneumonitis due to decreased inflammatory signaling. </plain></SENT>
</text></p><p><text><SENT sid="970" pm="."><plain>In all, the functional consequences of the variants identified as strongly associated with increased risk of normal tissue toxicity following radiation exposure suggest a high biological plausibility for our findings. </plain></SENT>
<SENT sid="971" pm="."><plain>However, little to no information is known about how these variants specifically alter pneumonitis and esophagitis risk. </plain></SENT>
<SENT sid="972" pm="."><plain>The inflammatory response is complex and many prototypic “proinflammatory” molecules have anti-inflammatory attributes under specific conditions, and vice versa. </plain></SENT>
<SENT sid="973" pm="."><plain>Further studies are warranted to elucidate the specific function of these SNPs in target tissues following exposure to radiation. </plain></SENT>
</text></p><p><text><SENT sid="974" pm="."><plain>Interestingly, we observed several variants with a trend towards a relationship between toxicity and overall survival, and only one SNP was identified as being associated with both. </plain></SENT>
<SENT sid="975" pm="."><plain>This result suggests that these patients who are developing acute normal tissue toxicity are responding well to therapy with longer survival times. </plain></SENT>
<SENT sid="976" pm="."><plain>Unfortunately, these side effects are dose limiting and often result in cessation of treatment. </plain></SENT>
<SENT sid="977" pm="."><plain>It may be that these select patients would receive the most benefit from the inclusion of radioprotective agents such as amifostine and glutamine in their treatment regimen. </plain></SENT>
<SENT sid="978" pm="."><plain>Both work by decreasing the levels of reactive oxygen species in the exposed normal tissue and, thus, potentially avoiding the development of inflammation. </plain></SENT>
<SENT sid="979" pm="."><plain>It would be of interest to test the significant SNPs identified in this study within the framework of these agents. </plain></SENT>
</text></p><p><text><SENT sid="980" pm="."><plain>Our study has several advantages, including the patient population with availability of comprehensive clinical and epidemiological information. </plain></SENT>
<SENT sid="981" pm="."><plain>To our knowledge, no study has systematically investigated the effect of genetic variations within inflammation-related genes and risk of normal tissue toxicity due to radiation therapy. </plain></SENT>
<SENT sid="982" pm="."><plain>This pathway-based approach allowed us to comprehensively elucidate the cumulative effects of multiple adverse alleles on toxicity risk. </plain></SENT>
<SENT sid="983" pm="."><plain>Since a patient's genome can contain several of these risk associated genetic variants in both proinflammatory and anti-inflammatory pathways, this approach is much more powerful in detecting the effect of these SNPs on a patient's risk of developing esophagitis or pneumonitis. </plain></SENT>
<SENT sid="984" pm="."><plain>The variants included in this study were candidate SNPs based on known or predicted effects on gene function. </plain></SENT>
<SENT sid="985" pm="."><plain>A candidate-gene approach has the advantage of being anchored by known biological plausibility, but there is a possibility that this study has missed additional risk alleles or detected a variant in linkage disequilibrium with the true causative SNP. </plain></SENT>
<SENT sid="986" pm="."><plain>In addition, we were not able to include additional variables that may also impact toxicity, including radiation field size, dose to organ at risk (esophagus and lung), treatment volume, and tumor location. </plain></SENT>
</text></p><p><text><SENT sid="987" pm="."><plain>In conclusion, we identified several biologically plausible associations between genetic variants in important inflammation-related genes and risk of developing esophagitis and pneumonitis. </plain></SENT>
<SENT sid="988" pm="."><plain>We also demonstrated a dose-effect of inflammation SNPs as evidenced by the dramatic increases in risk with increases in number of unfavorable genotypes. </plain></SENT>
<SENT sid="989" pm="."><plain>Furthermore, we identified one variant in IL10 that is associated with increased risk of esophagitis, but a decreased risk of dying. </plain></SENT>
<SENT sid="990" pm="."><plain>Since radiotherapy is a mainstay of lung cancer treatment, having the ability to screen patients prior to initiation of treatment would potentially minimize these acute toxicity events while allowing for higher doses of radiation for those who are not at increased risk in order to improve local control. </plain></SENT>
<SENT sid="991" pm="."><plain>With validation, these results, together with clinical and dosimetric predictors, could serve to increase the overall benefit of radiation therapy in NSCLC patients. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s4"><title><text><SENT sid="992" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="s4a"><title><text><SENT sid="993" pm="."><plain>Ethics Statement </plain></SENT>
</text></title><p><text><SENT sid="994" pm="."><plain>Participants gave written informed consent and the study was approved by The University of Texas MD Anderson Cancer Center's Institutional Review Board. </plain></SENT>
</text></p></sec><sec id="s4b"><title><text><SENT sid="995" pm="."><plain>Patient Population </plain></SENT>
</text></title><p><text><SENT sid="996" pm="."><plain>The study included non-Hispanic Caucasian subjects who were newly diagnosed, histologically confirmed stage IIIA or IIIB without a malignant effusion (dry) NSCLC patients receiving definitive thoracic radiation or chemoradiation therapy at The University of Texas MD Anderson Cancer Center. </plain></SENT>
<SENT sid="997" pm="."><plain>All of the patients were enrolled in an ongoing epidemiology lung cancer study between 1995 and 2007. </plain></SENT>
</text></p></sec><sec id="s4c"><title><text><SENT sid="998" pm="."><plain>Epidemiological and Clinical Data Collection </plain></SENT>
</text></title><p><text><SENT sid="999" pm="."><plain>Epidemiologic data were collected during an in-person interview using a structured questionnaire to determine demographic characteristics, medical history, and smoking history. </plain></SENT>
<SENT sid="1000" pm="."><plain>Clinical and follow-up information was abstracted from medical records. </plain></SENT>
<SENT sid="1001" pm="."><plain>Pre-treatment performance status was determined based on the Eastern Cooperative Oncology Group scale. </plain></SENT>
<SENT sid="1002" pm="."><plain>Radiation-induced esophagitis was characterized by documentation of new-onset pain on swallowing occurring during treatment. </plain></SENT>
<SENT sid="1003" pm="."><plain>Pneumonitis was detected by roentgenographic or CT scan abnormalities and often associated with nonproductive cough and/or fever. </plain></SENT>
<SENT sid="1004" pm="."><plain>Severity of pneumonitis or esophagitis was scored by the physician according to National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0) guidelines [45]. </plain></SENT>
<SENT sid="1005" pm="."><plain>For this study, an event was considered the occurrence of grade ≥2 toxicity. </plain></SENT>
</text></p></sec><sec id="s4d"><title><text><SENT sid="1006" pm="."><plain>SNP Selection and Genotyping </plain></SENT>
</text></title><p><text><SENT sid="1007" pm="."><plain>Blood was drawn from each participant following the in-person interview. </plain></SENT>
<SENT sid="1008" pm="."><plain>These samples were used to extract genomic DNA from peripheral blood lymphocytes using the Human Whole Blood Genomic DNA Extraction Kit (Qiagen, Valencia, CA). </plain></SENT>
<SENT sid="1009" pm="."><plain>A total of 59 candidate SNPs ( Table 5 ) were selected from 37 known inflammation-related genes as previously described [46]. </plain></SENT>
<SENT sid="1010" pm="."><plain>Briefly, candidate SNPs were selected if they had a minor allele frequency greater than 5% and were located in a putative functional region of the gene (promoter, untranslated regions (UTR) or exons) or had previously been reported as associated with cancer or an inflammatory disorder. </plain></SENT>
<SENT sid="1011" pm="."><plain>Genotyping was performed using the SNPlex assay following manufacturer's instructions (Applied Biosystems, Foster City, CA) with analysis on an Applied Biosystems 3730 DNA Analyzer. </plain></SENT>
<SENT sid="1012" pm="."><plain>SNP genotypes were called using the GeneMapper software (Applied Biosystems). </plain></SENT>
<SENT sid="1013" pm="."><plain>Three SNPs: IL8RA:rs2234671, LTA:rs2229092 and IL4R:rs1805011 were removed because of excessive missing genotypes (&gt;20%). </plain></SENT>
<SENT sid="1014" pm="."><plain>All genotyping was completed blinded with regard to toxicity status. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0012402-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0012402.t005</object-id><label>Table5</label><caption><title><text><SENT sid="1015" pm="."><plain>Inflammation single nucleotide polymorphism characteristics. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0012402-t005-5" xlink:href="pone.0012402.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1016" pm="."><plain>dbSNP ID </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1017" pm="."><plain>Alleles </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1018" pm="."><plain>Gene Symbol </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1019" pm="."><plain>Gene Name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1020" pm="."><plain>SNP Location* </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1021" pm="."><plain>rs1800872 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1022" pm="."><plain>C/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1023" pm="."><plain>IL10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1024" pm="."><plain>interleukin 10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1025" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1026" pm="."><plain>rs1800896 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1027" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1028" pm="."><plain>IL10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1029" pm="."><plain>interleukin 10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1030" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1031" pm="."><plain>rs1900871 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1032" pm="."><plain>A/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1033" pm="."><plain>IL10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1034" pm="."><plain>interleukin 10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1035" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1036" pm="."><plain>rs3135932 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1037" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1038" pm="."><plain>IL10RA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1039" pm="."><plain>interleukin 10 receptor, alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1040" pm="."><plain>Ser159Gly </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1041" pm="."><plain>rs2834167 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1042" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1043" pm="."><plain>IL10RB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1044" pm="."><plain>interleukin 10 receptor, beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1045" pm="."><plain>Lys47Glu </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1046" pm="."><plain>rs1800925 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1047" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1048" pm="."><plain>IL13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1049" pm="."><plain>interleukin 13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1050" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1051" pm="."><plain>rs20541 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1052" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1053" pm="."><plain>IL13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1054" pm="."><plain>interleukin 13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1055" pm="."><plain>Arg130Gln </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1056" pm="."><plain>rs2070874 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1057" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1058" pm="."><plain>IL4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1059" pm="."><plain>interleukin 4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1060" pm="."><plain>5'-UTR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1061" pm="."><plain>rs2243250 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1062" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1063" pm="."><plain>IL4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1064" pm="."><plain>interleukin 4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1065" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1066" pm="."><plain>rs1801275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1067" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1068" pm="."><plain>IL4R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1069" pm="."><plain>interleukin 4 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1070" pm="."><plain>Gln576Arg </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1071" pm="."><plain>rs1805010 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1072" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1073" pm="."><plain>IL4R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1074" pm="."><plain>interleukin 4 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1075" pm="."><plain>Ile75Val </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1076" pm="."><plain>rs1805011 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1077" pm="."><plain>A/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1078" pm="."><plain>IL4R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1079" pm="."><plain>interleukin 4 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1080" pm="."><plain>Glu400Ala </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1081" pm="."><plain>rs1805015 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1082" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1083" pm="."><plain>IL4R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1084" pm="."><plain>interleukin 4 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1085" pm="."><plain>Ser503Pro </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1086" pm="."><plain>rs1805016 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1087" pm="."><plain>T/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1088" pm="."><plain>IL4R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1089" pm="."><plain>interleukin 4 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1090" pm="."><plain>Ser752Ala </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1091" pm="."><plain>rs2069812 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1092" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1093" pm="."><plain>IL5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1094" pm="."><plain>interleukin 5 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1095" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1096" pm="."><plain>rs2233409 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1097" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1098" pm="."><plain>NFKBIA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1099" pm="."><plain>IkB alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1100" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1101" pm="."><plain>rs8904 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1102" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1103" pm="."><plain>NFKBIA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1104" pm="."><plain>IkB alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1105" pm="."><plain>3'-UTR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1106" pm="."><plain>rs1800206 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1107" pm="."><plain>C/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1108" pm="."><plain>PPARA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1109" pm="."><plain>peroxisome proliferator-activated receptor alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1110" pm="."><plain>Leu162Val </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1111" pm="."><plain>rs2016520 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1112" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1113" pm="."><plain>PPARD </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1114" pm="."><plain>peroxisome proliferator-activated receptor delta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1115" pm="."><plain>5'-UTR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1116" pm="."><plain>rs1801282 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1117" pm="."><plain>C/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1118" pm="."><plain>PPARG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1119" pm="."><plain>peroxisome proliferator-activated receptor gamma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1120" pm="."><plain>Pro12Ala </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1121" pm="."><plain>rs1024611 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1122" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1123" pm="."><plain>CCL2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1124" pm="."><plain>chemokine (C-C motif) ligand 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1125" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1126" pm="."><plain>rs2069614 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1127" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1128" pm="."><plain>CSF2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1129" pm="."><plain>colony stimulating factor 2 (granulocyte-macrophage) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1130" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1131" pm="."><plain>rs25882 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1132" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1133" pm="."><plain>CSF2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1134" pm="."><plain>colony stimulating factor 2 (granulocyte-macrophage) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1135" pm="."><plain>Ile117Thr </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1136" pm="."><plain>rs2257167 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1137" pm="."><plain>G/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1138" pm="."><plain>IFNAR1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1139" pm="."><plain>interferon (alpha, beta and omega) receptor 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1140" pm="."><plain>Val168Leu </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1141" pm="."><plain>rs1051393 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1142" pm="."><plain>T/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1143" pm="."><plain>IFNAR2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1144" pm="."><plain>interferon (alpha, beta and omega) receptor 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1145" pm="."><plain>Phe10Val </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1146" pm="."><plain>rs2069705 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1147" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1148" pm="."><plain>IFNG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1149" pm="."><plain>interferon, gamma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1150" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1151" pm="."><plain>rs2430561 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1152" pm="."><plain>A/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1153" pm="."><plain>IFNG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1154" pm="."><plain>interferon, gamma </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1155" pm="."><plain>intron </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1156" pm="."><plain>rs3212227 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1157" pm="."><plain>A/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1158" pm="."><plain>IL12B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1159" pm="."><plain>interleukin 12B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1160" pm="."><plain>3'-UTR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1161" pm="."><plain>rs375947 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1162" pm="."><plain>A/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1163" pm="."><plain>IL12RB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1164" pm="."><plain>interleukin 12 receptor, beta 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1165" pm="."><plain>Met365Thr </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1166" pm="."><plain>rs11556218 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1167" pm="."><plain>T/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1168" pm="."><plain>IL16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1169" pm="."><plain>interleukin 16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1170" pm="."><plain>Asn446Lys </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1171" pm="."><plain>rs4778889 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1172" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1173" pm="."><plain>IL16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1174" pm="."><plain>interleukin 16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1175" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1176" pm="."><plain>rs17561 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1177" pm="."><plain>G/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1178" pm="."><plain>IL1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1179" pm="."><plain>interleukin 1, alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1180" pm="."><plain>Ala114Ser </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1181" pm="."><plain>rs1800587 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1182" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1183" pm="."><plain>IL1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1184" pm="."><plain>interleukin 1, alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1185" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1186" pm="."><plain>rs1143627 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1187" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1188" pm="."><plain>IL1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1189" pm="."><plain>interleukin 1, beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1190" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1191" pm="."><plain>rs1143634 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1192" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1193" pm="."><plain>IL1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1194" pm="."><plain>interleukin 1, beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1195" pm="."><plain>Phe105Phe </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1196" pm="."><plain>rs16944 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1197" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1198" pm="."><plain>IL1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1199" pm="."><plain>interleukin 1, beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1200" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1201" pm="."><plain>rs2228139 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1202" pm="."><plain>C/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1203" pm="."><plain>IL1R1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1204" pm="."><plain>interleukin 1 receptor, type I </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1205" pm="."><plain>Ala124Gly </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1206" pm="."><plain>rs2069762 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1207" pm="."><plain>T/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1208" pm="."><plain>IL2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1209" pm="."><plain>interleukin 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1210" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1211" pm="."><plain>rs228942 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1212" pm="."><plain>C/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1213" pm="."><plain>IL2RB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1214" pm="."><plain>interleukin 2 receptor, beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1215" pm="."><plain>Asp391Glu </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1216" pm="."><plain>rs1800795 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1217" pm="."><plain>C/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1218" pm="."><plain>IL6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1219" pm="."><plain>interleukin 6 (interferon, beta 2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1220" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1221" pm="."><plain>rs2228145 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1222" pm="."><plain>A/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1223" pm="."><plain>IL6R </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1224" pm="."><plain>interleukin 6 receptor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1225" pm="."><plain>Asp358Ala </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1226" pm="."><plain>rs4073 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1227" pm="."><plain>T/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1228" pm="."><plain>IL8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1229" pm="."><plain>interleukin 8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1230" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1231" pm="."><plain>rs2234671 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1232" pm="."><plain>G/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1233" pm="."><plain>IL8RA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1234" pm="."><plain>interleukin 8 receptor, alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1235" pm="."><plain>Ser276Thr </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1236" pm="."><plain>rs2229092 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1237" pm="."><plain>A/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1238" pm="."><plain>LTA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1239" pm="."><plain>lymphotoxin alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1240" pm="."><plain>His51Pro </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1241" pm="."><plain>rs2229094 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1242" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1243" pm="."><plain>LTA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1244" pm="."><plain>lymphotoxin alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1245" pm="."><plain>Arg13Cys </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1246" pm="."><plain>rs755622 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1247" pm="."><plain>C/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1248" pm="."><plain>MIF </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1249" pm="."><plain>macrophage migration inhibitory factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1250" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1251" pm="."><plain>rs1799724 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1252" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1253" pm="."><plain>TNF </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1254" pm="."><plain>tumor necrosis factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1255" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1256" pm="."><plain>rs1799964 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1257" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1258" pm="."><plain>TNF </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1259" pm="."><plain>tumor necrosis factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1260" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1261" pm="."><plain>rs1800629 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1262" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1263" pm="."><plain>TNF </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1264" pm="."><plain>tumor necrosis factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1265" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1266" pm="."><plain>rs361525 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1267" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1268" pm="."><plain>TNF </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1269" pm="."><plain>tumor necrosis factor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1270" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1271" pm="."><plain>rs4149570 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1272" pm="."><plain>G/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1273" pm="."><plain>TNFRSF1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1274" pm="."><plain>tumor necrosis factor receptor superfamily, member 1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1275" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1276" pm="."><plain>rs4149584 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1277" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1278" pm="."><plain>TNFRSF1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1279" pm="."><plain>tumor necrosis factor receptor superfamily, member 1A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1280" pm="."><plain>Arg121Gln </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1281" pm="."><plain>rs1061622 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1282" pm="."><plain>T/G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1283" pm="."><plain>TNFRSF1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1284" pm="."><plain>tumor necrosis factor receptor superfamily, member 1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1285" pm="."><plain>Met196Arg </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1286" pm="."><plain>rs5746026 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1287" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1288" pm="."><plain>TNFRSF1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1289" pm="."><plain>tumor necrosis factor receptor superfamily, member 1B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1290" pm="."><plain>Glu232Lys </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1291" pm="."><plain>rs2297518 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1292" pm="."><plain>G/A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1293" pm="."><plain>NOS2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1294" pm="."><plain>nitric oxide synthase 2, inducible </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1295" pm="."><plain>Leu608Ser </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1296" pm="."><plain>rs1799983 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1297" pm="."><plain>G/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1298" pm="."><plain>NOS3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1299" pm="."><plain>nitric oxide synthase 3 (endothelial cell) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1300" pm="."><plain>Glu298Asp </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1301" pm="."><plain>rs20417 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1302" pm="."><plain>G/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1303" pm="."><plain>PTGS2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1304" pm="."><plain>prostaglandin-endoperoxide synthase 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1305" pm="."><plain>5'-FR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1306" pm="."><plain>rs5275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1307" pm="."><plain>T/C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1308" pm="."><plain>PTGS2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1309" pm="."><plain>prostaglandin-endoperoxide synthase 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1310" pm="."><plain>3'-UTR </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="1311" pm="."><plain>rs689470 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1312" pm="."><plain>C/T </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1313" pm="."><plain>PTGS2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1314" pm="."><plain>prostaglandin-endoperoxide synthase 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="1315" pm="."><plain>3'-UTR </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt110"><label/><p><text><SENT sid="1316" pm="."><plain>*FR: flanking region, UTR: untranslated region. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s4e"><title><text><SENT sid="1317" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="1318" pm="."><plain>Time to event (grade ≥2 pneumonitis or esophagitis) was based on the duration from start of radiation treatment to occurrence of toxicity. </plain></SENT>
<SENT sid="1319" pm="."><plain>Three-year survival was also defined as the time from start of radiation treatment to the date of death or the date of last follow-up during the three year period. </plain></SENT>
<SENT sid="1320" pm="."><plain>Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for each individual SNP and endpoint combination were estimated by fitting the Cox proportional hazard model while adjusting for age, gender, clinical stage, pack years of smoking, pre-treatment performance status, treatment regimen (radiotherapy or chemoradiotherapy), radiation type, and radiation dosage. </plain></SENT>
<SENT sid="1321" pm="."><plain>Kaplan-Meier curves and log-rank tests were used to assess differences in time to event and overall survival rates. </plain></SENT>
<SENT sid="1322" pm="."><plain>Combined effects of unfavorable genotypes were based on the main effect analysis of individual SNPs and included those with significant (P&lt;0.05) and borderline significant (P&lt;0.10) associations. </plain></SENT>
<SENT sid="1323" pm="."><plain>STATA software (version 10, STATA Corp., College Station, TX) was used for statistical analyses. </plain></SENT>
<SENT sid="1324" pm="."><plain>Q-values were calculated to control for multiple comparisons based on an FDR value of 10% [47]. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><fn-group><fn fn-type="COI-statement"><p><text><SENT sid="1325" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><SecTag type="ACK_FUND"><fn fn-type="financial-disclosure"><p><text4fund><text><SENT sid="1326" pm="."><plain>Funding: This work was supported by National Cancer Institute grants R01 CA111646, P50 CA070907, R01 CA127219, and R01 CA55769. </plain></SENT>
<SENT sid="1327" pm="."><plain>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. </plain></SENT>
</text></text4fund></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0012402-Jemal1"><text><SENT sid="1328" pm="."><plain>1 JemalASiegelRWardEHaoYXuJ 2008 Cancer statistics, 2008. CA Cancer J Clin 58 71 96 18287387 </plain></SENT>
</text></ref><ref id="pone.0012402-Spira1"><text><SENT sid="1329" pm="."><plain>2 SpiraAEttingerDS 2004 Multidisciplinary management of lung cancer. N Engl J Med 350 379 392 14736930 </plain></SENT>
</text></ref><ref id="pone.0012402-Greenlee1"><text><SENT sid="1330" pm="."><plain>3 GreenleeRTMurrayTBoldenSWingoPA 2000 Cancer statistics, 2000. CA Cancer J Clin 50 7 33 10735013 </plain></SENT>
</text></ref><ref id="pone.0012402-Rubin1"><text><SENT sid="1331" pm="."><plain>4 RubinPJohnstonCJWilliamsJPMcDonaldSFinkelsteinJN 1995 A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 99 109 7642437 </plain></SENT>
</text></ref><ref id="pone.0012402-Robnett1"><text><SENT sid="1332" pm="."><plain>5 RobnettTJMachtayMVinesEFMcKennaMGAlgazyKM 2000 Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48 89 94 10924976 </plain></SENT>
</text></ref><ref id="pone.0012402-Rose1"><text><SENT sid="1333" pm="."><plain>6 RoseJRodriguesGYaremkoBLockMD'SouzaD 2008 Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol  </plain></SENT>
</text></ref><ref id="pone.0012402-Singh1"><text><SENT sid="1334" pm="."><plain>7 SinghAKLockettMABradleyJD 2003 Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 337 341 12527046 </plain></SENT>
</text></ref><ref id="pone.0012402-Tucker1"><text><SENT sid="1335" pm="."><plain>8 TuckerSLLiuHHLiaoZWeiXWangS 2008 Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys 72 568 574 18793959 </plain></SENT>
</text></ref><ref id="pone.0012402-Wang1"><text><SENT sid="1336" pm="."><plain>9 WangSLiaoZWeiXLiuHHTuckerSL 2006 Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 1399 1407 16997503 </plain></SENT>
</text></ref><ref id="pone.0012402-Dinarello1"><text><SENT sid="1337" pm="."><plain>10 DinarelloCA 2000 Proinflammatory cytokines. Chest 118 503 508 10936147 </plain></SENT>
</text></ref><ref id="pone.0012402-Opal1"><text><SENT sid="1338" pm="."><plain>11 OpalSMDePaloVA 2000 Anti-inflammatory cytokines. Chest 117 1162 1172 10767254 </plain></SENT>
</text></ref><ref id="pone.0012402-Barnett1"><text><SENT sid="1339" pm="."><plain>12 BarnettGCWestCMDunningAMElliottRMColesCE 2009 Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9 134 142 19148183 </plain></SENT>
</text></ref><ref id="pone.0012402-Andreassen1"><text><SENT sid="1340" pm="."><plain>13 AndreassenCNAlsnerJOvergaardMOvergaardJ 2003 Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 127 135 14643949 </plain></SENT>
</text></ref><ref id="pone.0012402-Andreassen2"><text><SENT sid="1341" pm="."><plain>14 AndreassenCNAlsnerJOvergaardJ 2002 Does variability in normal tissue reactions after radiotherapy have a genetic basis—where and how to look for it? Radiother Oncol 64 131 140 12242122 </plain></SENT>
</text></ref><ref id="pone.0012402-Andreassen3"><text><SENT sid="1342" pm="."><plain>15 AndreassenCNAlsnerJOvergaardJHerskindCHavilandJ 2005 TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75 18 21 15878096 </plain></SENT>
</text></ref><ref id="pone.0012402-Finkelstein1"><text><SENT sid="1343" pm="."><plain>16 FinkelsteinJNJohnstonCJBaggsRRubinP 1994 Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 28 621 631 8113105 </plain></SENT>
</text></ref><ref id="pone.0012402-Quarmby1"><text><SENT sid="1344" pm="."><plain>17 QuarmbySFakhouryHLevineEBarberJWylieJ 2003 Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 137 143 12569017 </plain></SENT>
</text></ref><ref id="pone.0012402-Kiszel1"><text><SENT sid="1345" pm="."><plain>18 KiszelPMakoVProhaszkaZCervenakL 2007 Interleukin-6 -174 promoter polymorphism does not influence IL-6 production after LPS and IL-1 beta stimulation in human umbilical cord vein endothelial cells. Cytokine 40 17 22 17869127 </plain></SENT>
</text></ref><ref id="pone.0012402-Terry1"><text><SENT sid="1346" pm="."><plain>19 TerryCFLoukaciVGreenFR 2000 Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 18138 18144 10747905 </plain></SENT>
</text></ref><ref id="pone.0012402-Huth1"><text><SENT sid="1347" pm="."><plain>20 HuthCIlligTHerderCGiegerCGrallertH 2008 Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G &gt;C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 1 21  </plain></SENT>
</text></ref><ref id="pone.0012402-Gao1"><text><SENT sid="1348" pm="."><plain>21 GaoLBRaoLWangYYLiangWBLiC 2009 The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30 295 299 19073878 </plain></SENT>
</text></ref><ref id="pone.0012402-Hill1"><text><SENT sid="1349" pm="."><plain>22 HillMRPapafiliABoothHLawsonPHubnerM 2006 Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 174 915 922 16840740 </plain></SENT>
</text></ref><ref id="pone.0012402-Papafili1"><text><SENT sid="1350" pm="."><plain>23 PapafiliAHillMRBrullDJMcAnultyRJMarshallRP 2002 Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22 1631 1636 12377741 </plain></SENT>
</text></ref><ref id="pone.0012402-Dixon1"><text><SENT sid="1351" pm="."><plain>24 DixonDA 2004 Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10 635 646 14965326 </plain></SENT>
</text></ref><ref id="pone.0012402-Hershey1"><text><SENT sid="1352" pm="."><plain>25 HersheyGKFriedrichMFEssweinLAThomasMLChatilaTA 1997 The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337 1720 1725 9392697 </plain></SENT>
</text></ref><ref id="pone.0012402-Crawley1"><text><SENT sid="1353" pm="."><plain>26 CrawleyEKayRSillibourneJPatelPHutchinsonI 1999 Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42 1101 1108 10366102 </plain></SENT>
</text></ref><ref id="pone.0012402-Gasche1"><text><SENT sid="1354" pm="."><plain>27 GascheCGrundtnerPZwirnPReinischWShawSH 2003 Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production. J Immunol 170 5578 5582 12759436 </plain></SENT>
</text></ref><ref id="pone.0012402-Dominici1"><text><SENT sid="1355" pm="."><plain>28 DominiciRCattaneoMMalferrariGArchiDMarianiC 2002 Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54 82 86 12037600 </plain></SENT>
</text></ref><ref id="pone.0012402-Kawaguchi1"><text><SENT sid="1356" pm="."><plain>29 KawaguchiYTochimotoAHaraMKawamotoMSugiuraT 2007 Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 59 441 448 17440718 </plain></SENT>
</text></ref><ref id="pone.0012402-Hull1"><text><SENT sid="1357" pm="."><plain>30 HullJThomsonAKwiatkowskiD 2000 Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55 1023 1027 11083887 </plain></SENT>
</text></ref><ref id="pone.0012402-Kabesch1"><text><SENT sid="1358" pm="."><plain>31 KabeschMTzotchevaICarrDHoflerCWeilandSK 2003 A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 112 893 898 14610476 </plain></SENT>
</text></ref><ref id="pone.0012402-Vladich1"><text><SENT sid="1359" pm="."><plain>32 VladichFDBrazilleSMSternDPeckMLGhittoniR 2005 IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 115 747 754 15711639 </plain></SENT>
</text></ref><ref id="pone.0012402-Cameron1"><text><SENT sid="1360" pm="."><plain>33 CameronLWebsterRBStrempelJMKieslerPKabeschM 2006 Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C&gt;T, a polymorphism associated with allergic inflammation. J Immunol 177 8633 8642 17142763 </plain></SENT>
</text></ref><ref id="pone.0012402-Hohjoh1"><text><SENT sid="1361" pm="."><plain>34 HohjohHTokunagaK 2001 Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2 105 109 11393654 </plain></SENT>
</text></ref><ref id="pone.0012402-Higuchi1"><text><SENT sid="1362" pm="."><plain>35 HiguchiTSekiNKamizonoSYamadaAKimuraA 1998 Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 605 612 9694352 </plain></SENT>
</text></ref><ref id="pone.0012402-Lv1"><text><SENT sid="1363" pm="."><plain>36 LvKChenRCaiQFangMSunS 2006 Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand J Immunol 64 164 169 16867162 </plain></SENT>
</text></ref><ref id="pone.0012402-Soga1"><text><SENT sid="1364" pm="."><plain>37 SogaYNishimuraFOhyamaHMaedaHTakashibaS 2003 Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 30 524 531 12795791 </plain></SENT>
</text></ref><ref id="pone.0012402-Puthothu1"><text><SENT sid="1365" pm="."><plain>38 PuthothuBBierbaumSKoppMVForsterJHeinzeJ 2008 Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol  </plain></SENT>
</text></ref><ref id="pone.0012402-Sato1"><text><SENT sid="1366" pm="."><plain>39 SatoHSilveiraLFingerlinTDockstaderKGillespieM 2007 TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 119 687 696 17208287 </plain></SENT>
</text></ref><ref id="pone.0012402-vanHeel1"><text><SENT sid="1367" pm="."><plain>40 van HeelDAUdalovaIADe SilvaAPMcGovernDPKinouchiY 2002 Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 11 1281 1289 12019209 </plain></SENT>
</text></ref><ref id="pone.0012402-Morita1"><text><SENT sid="1368" pm="."><plain>41 MoritaCHoriuchiTTsukamotoHHattaNKikuchiY 2001 Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum 44 2819 2827 11762942 </plain></SENT>
</text></ref><ref id="pone.0012402-Till1"><text><SENT sid="1369" pm="."><plain>42 TillARosenstielPKrippner-HeidenreichAMascheretti-CroucherSCroucherPJ 2005 The Met-196 -&gt; Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. J Biol Chem 280 5994 6004 15572357 </plain></SENT>
</text></ref><ref id="pone.0012402-Wang2"><text><SENT sid="1370" pm="."><plain>43 WangXLSimASWangMXMurrellGATrudingerB 2000 Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471 45 50 10760510 </plain></SENT>
</text></ref><ref id="pone.0012402-Veldman1"><text><SENT sid="1371" pm="."><plain>44 VeldmanBASpieringWDoevendansPAVervoortGKroonAA 2002 The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20 2023 2027 12359981 </plain></SENT>
</text></ref><ref id="pone.0012402-Trotti1"><text><SENT sid="1372" pm="."><plain>45 TrottiAColevasADSetserARuschVJaquesD 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 176 181 12903007 </plain></SENT>
</text></ref><ref id="pone.0012402-Engels1"><text><SENT sid="1373" pm="."><plain>46 EngelsEAWuXGuJDongQLiuJ 2007 Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 67 6520 6527 17596594 </plain></SENT>
</text></ref><ref id="pone.0012402-Storey1"><text><SENT sid="1374" pm="."><plain>47 StoreyJD 2002 A direct approch to false discovery rates. J R Stat Soc B 64 479 498  </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
